Rationale for a Neisseria gonorrhoeae Susceptible Only Interpretive Breakpoint for Azithromycin

BACKGROUND: Azithromycin (AZI) is recommended with Ceftriaxone (CRO) for treatment of uncomplicated gonococcal urethritis and cervicitis in the United States (US) and an AZI susceptibility breakpoint is needed. Neither the FDA (Food and Drug Administration) nor the CLSI (Clinical and Laboratory Stan...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Infect Dis
Huvudupphovsmän: Kersh, Ellen N., Allen, Vanessa, Ransom, Eric, Schmerer, Matthew, St. Cyr, Sancta, Workowski, Kim, Weinstock, Hillard, Patel, Jean, Ferraro, Mary Jane
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785360/
https://ncbi.nlm.nih.gov/pubmed/30963175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz292
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk